Clinical and immunological correlates of long term survival in glioblastoma

Glioblastoma (GBM) is the most common and most aggressive type of primary brain tumour in adults. It represents 54% of all gliomas and 16% of all brain tumours (Ostrom et al. 2016). Despite surgery and treatment with radiotherapy plus an oral alkylating agent, temozolomide (TMZ), tumours invariably...

Descripción completa

Detalles Bibliográficos
Autores principales: Czapski, Bartosz, Baluszek, Szymon, Herold-Mende, Christel, Kaminska, Bozena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885076/
https://www.ncbi.nlm.nih.gov/pubmed/29628799
http://dx.doi.org/10.5114/wo.2018.73893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885076/
https://www.ncbi.nlm.nih.gov/pubmed/29628799
http://dx.doi.org/10.5114/wo.2018.73893

Ejemplares similares